Urinary Titin Biomarker in DMD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Urinary Titin Biomarker in DMD — Stella

Recruiting

Back to Duchenne Muscular Dystrophy (DMD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Key details

Sponsor

Children's Hospital of Philadelphia

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~50 participants

Started

March 2026

Primary completion

December 2029

Age range

2 Years – 10 Years

Sex

Male only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov